Skip to main content
SpringerLink
Log in

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2

  • Book
  • © 1996

Overview

Editors:
  1. H. M. Pinedo

    1. Free University, Amsterdam, The Netherlands

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. J. H. Schornagel

    1. Netherlands Cancer Institute, Amsterdam, The Netherlands

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (32 chapters)

  1. Front Matter

    Pages i-ix
    Download chapter PDF

  2. Synthesis and Activity of Platinum Compounds

    1. NMR Spectroscopy of Platinum Drugs: From DNA to Body Fluids

      • Kevin J. Barnham, Susan J. Berners-Price, Zijian Guo, Piedad del Socorro Murdoch, Peter J. Sadler
      Pages 1-16

    2. Trans-Diamminedichloroplatinum (II) Is Not an Antitumor Drug: Why?

      • Rozenn Dalbiès, Marc Boudvillain, Marc Leng
      Pages 17-25

    3. Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity

      • Mauro Coluccia, Maria A. Mariggiò, Angela Boccarelli, Francesco Loseto, Nicola Cardellicchio, Paola Caputo et al.
      Pages 27-35

    4. Molecular Dynamics Simulations of Cisplatin Adducts with Dinucleotides

      • Jiří Kozelka
      Pages 37-42

    5. Orally Active DACH-Pt (IV) Compounds

      • Yoshinori Kidani, Ryoichi Kizu, Motoichi Miyazaki, Masahide Noji, Akio Matsuzawa, Yasutaka Takeda et al.
      Pages 43-51

  3. Clinical Pharmacology

    1. Pharmacokinetic — Pharmacodynamic Relationships

      • Pierre Canal, Etienne Chatelut
      Pages 53-66

    2. Clinical Pharmacology of Carboplatin Administered in Alternating Sequence with Paclitaxel in Patients with Non-Small Cell Lung Cancer: A European Cancer Centre (ECC) Study

      • L. J. C. van Warmerdam, M. T. Huizing, G. Giaccone, P. J. M. Bakker, J. B. Vermorken, P. E. Postmus et al.
      Pages 67-82

    3. The Clinical Development of the Oral Platinum Anticancer Agent JM216

      • Ian Judson, Mark McKeage, Janet Hanwell, Claire Berry, Prakash Mistry, Florence Raynaud et al.
      Pages 83-89

  4. Biochemistry and Molecular Pharmacology

    1. Membrane Transport of Platinum Compounds

      • Gerrit Los, Dennis Gately, Michael L. Costello, Franz Thiebaut, Peter Naredi, Stephen B. Howell
      Pages 91-105

    2. Detection of Adducts Formed upon Treatment of DNA with Cisplatin and Carboplatin

      • Anne Marie J. Fichtinger-Schepman, Marij J. P. Welters, Helma C. M. van Dijk-Knijnenburg, Marianne L. T. van der Sterre, Michael J. Tilby, Frits Berends et al.
      Pages 107-119

    3. Detection of Platinum Lesions at the Nucleotide Level in Cells using Single Strand Ligation PCR

      • John A. Hartley, Robert L. Souhami, Keith A. Grimaldi
      Pages 121-130

    4. A Review of the Modulation of Cisplatin Toxicities by Chemoprotectants

      • Robert T. Dorr
      Pages 131-154

    5. Combination Therapy with Cisplatinum and EGF Receptor Blockade

      • John Mendelsohn, Zhen Fan, Jose Baselga
      Pages 155-163

  5. Clinical Studies

    1. Oxaliplatin: Update on a Active and Safe Dach Platinum Complex

      • P. Soulié, E. Raymond, J. L. Misset, E. Cvitkovic
      Pages 165-174

    2. Combination of Different Platinum Compounds: Issues, Strategies, and Experience

      • Franco M. Muggia
      Pages 175-179

    3. Phase I and II Studies with Lobaplatin

      • H. H. Fiebig
      Pages 181-186

    4. Phase I Trials of Ormaplatin (NSC 363812)

      • Michaele C. Christian
      Pages 187-192

    5. 254-S, NK121 and TRK710

      • Makoto Ogawa
      Pages 193-197

    6. Clinical Trials of Oxaliplatin and DWA2114R

      • T. Taguchi
      Pages 199-203
Back to top

Keywords

Editors and Affiliations

  • Free University, Amsterdam, The Netherlands

    H. M. Pinedo

  • Netherlands Cancer Institute, Amsterdam, The Netherlands

    J. H. Schornagel

Bibliographic Information

  • Book Title: Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2

  • Editors: H. M. Pinedo, J. H. Schornagel

  • DOI: https://doi.org/10.1007/978-1-4899-0218-4

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 1996

  • Hardcover ISBN: 978-0-306-45287-1Published: 30 April 1996

  • Softcover ISBN: 978-1-4899-0220-7Published: 20 June 2013

  • eBook ISBN: 978-1-4899-0218-4Published: 11 November 2013

  • Edition Number: 1

  • Number of Pages: X, 358

  • Topics: Oncology, Immunology, Biochemistry, general

Publish with us

Policies and ethics

Back to top

Search

Navigation